Population cardiac-risk infrastructure
Some heart rhythm problems happen between visits. MbeleMed helps find them.
A routine visit is only a snapshot. MbeleMed helps healthcare organizations identify people who may benefit from cardiac monitoring, make monitoring easier to access, have findings reviewed by qualified physicians, and connect meaningful findings to the right follow-up.
- Find the right people
- Monitor beyond the office
- Physician-reviewed findings
- Connect findings to follow-up
Why this matters
A normal day does not always mean a normal rhythm.
Heart rhythm problems can come and go. A person may feel completely fine when they see a doctor and still have an abnormal rhythm at another time.
That is why finding the right people to monitor, and making monitoring practical outside a specialist visit, matters.
MbeleMed helps connect the pieces.
- 01
Find the right people
Use clinical information and approved population criteria to identify people who may benefit from additional monitoring.
- 02
Reach people where care actually happens
Support monitoring through home, clinic, community, and mobile pathways.
- 03
Turn a finding into a next step
Potential findings go to qualified physician review, then into the partner's defined follow-up pathway.
One connected pathway
From a population signal to a person who knows what happens next.
- 01
Prioritize
Identify people whose clinical history and risk profile suggest that additional monitoring may be useful.
- 02
Reach
Coordinate outreach and monitoring in the setting that works for the person.
- 03
Monitor
Use an appropriate monitoring service selected for the population and program.
MbeleMed does not manufacture or own monitoring devices.
- 04
Review
Potential findings are reviewed by qualified physicians before clinical action.
- 05
Act
The responsible care team follows the agreed pathway for outreach, escalation, referral, or further evaluation.
- 06
Measure
Track who completed monitoring, what was found, what happened next, and what the program learned.
Technology coordinates the pathway. Clinicians remain in command.
Broader than AF
We are looking for meaningful rhythm problems, not just one diagnosis.
Atrial fibrillation matters. But it is not the only rhythm problem that can be clinically important.
Depending on the monitoring protocol and physician interpretation, programs can look for:
- Atrial fibrillation and flutter
- Supraventricular and atrial tachycardias
- Ventricular arrhythmias
- Bradycardia and significant pauses
- Conduction abnormalities, including AV block
- Clinically meaningful ectopy
- Other rhythm abnormalities supported by the selected protocol
The goal is not to force every person into one diagnosis.It is to find the findings that matter for the people being monitored.
Who we work with
Different organizations. One common problem.
Health Plans & Risk-Bearing Groups
Help identify members who may benefit from additional monitoring and build a pathway from finding to follow-up.
Explore Health PlansHealth Systems & Physician Groups
Extend access beyond traditional specialty care while keeping interpretation and clinical decisions with the care team.
Explore Health SystemsCommunity & Access Partners
Bring structured cardiac-risk workflows closer to rural, underserved, and difficult-to-reach populations.
Explore AccessStrategic & Research Partners
Connect monitoring, data, technology, clinical expertise, and research capabilities without blurring responsibility.
Explore Partnerships
Aligned by the finding
The goal is to reward meaningful clinical information, not more screening for its own sake.
MbeleMed is designed so the program's incentives can follow physician-confirmed actionable findings rather than simply the number of people screened.
That matters because the best screening program is not the one that monitors the most people. It is the one that reaches the right people, produces credible findings, and connects those findings to what happens next.
- SIGNAL
- PHYSICIAN REVIEW
- NEXT STEPagreed pathway
Evidence & research
The same pathway can teach us what to do better next time.
Every properly governed program can generate useful learning: who was reached, who completed monitoring, what was found, how findings were handled, and where the pathway worked or broke down.
MbeleMed is also developing research across senior and maternal cardiovascular populations, combining longitudinal clinical information with targeted continuous rhythm monitoring.
Research and clinical care remain separately governed.
Early momentum
Building carefully. Learning quickly.
MbeleMed is developing early pilot pathways with health-system and population-health partners while preparing multiple senior and maternal cardiovascular study submissions.
- 2026 BioNTX Rising Star
- Top 12 Finalist, WT Innovation World Cup USA 2026
Evidence maturity
We will tell you what we know, and what we are still learning.
The point is simple:Confidence should come from knowing exactly where the evidence stands.
MbeleMed separates:
- 01Published external evidence
- 02Internal modeled analysis
- 03Implemented workflow capability
- 04Synthetic demonstrations
- 05Pilot-stage work
- 06Research-stage methods
- 07Roadmap items
Start with a person, a population, and a question.
Tell us who you are trying to help, what the current pathway looks like, and what a first program needs to learn.